Promoting trustworthy AI that is consistent with the Union's values

Good afternoon, and welcome to the European Alliance for Personalised Medicine (EAPM) update – we hope you are all enjoying a good start to the week. All our news items below will be tracked by EAPM at EU and country level, writes EAPM Executive Director Dr. Denis Horgan. Pharma legislation delayed It’s one of the hottest […]

Related Keywords

Germany ,Italy ,Copenhagen ,Køavn ,Denmark ,United Kingdom ,Washington ,United States ,White House ,District Of Columbia ,Belgium ,Europe Hans Kluge ,Denis Horgan ,Didier Reynders ,Vincent Manancourt ,Max Schrems ,Joe Biden ,Yves Van Laethem ,Stella Kyriakides ,Mark Scott ,Van Laethem ,Andrea Ammon ,Committee Of Ministers ,European Commission ,European Expert Group Of Orphan Drug Incentives ,World Health Organization Regional ,Council Of Europe ,Council Of Europe Elsinore ,European Alliance For Personalised Medicine ,Council Decision ,European Union ,European Medicines Agency ,European Centre For Disease Prevention ,National Insurance ,Office For National Statistics ,England National Health Service ,European Alliance ,Personalised Medicine ,Reforming Europe ,Unmet Medical Need ,Towards Better Pharmaceutical Provision ,Who Decides ,Lorraine Nolan ,Clinical Trials Regulation ,Copenhagen Economics ,European Expert Group ,Orphan Drug ,Orphan Medicinal Products Regulation ,European Data Protection Supervisor ,Secretary General ,Commissioner Didier Reynders ,National Statistics ,Health Commissioner Stella Kyriakides ,World Health Organization Regional Director ,European Centre ,Disease Prevention ,Control Andrea ,National Health Service ,Liz Trus ,